174 related articles for article (PubMed ID: 26350916)
1. Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-analysis.
Barkas F; Elisaf M; Milionis H
Atherosclerosis; 2015 Nov; 243(1):60-4. PubMed ID: 26350916
[TBL] [Abstract][Full Text] [Related]
2. Risk of Ischemic Stroke and Peripheral Arterial Disease in Heterozygous Familial Hypercholesterolemia: A Meta-Analysis.
Akioyamen LE; Tu JV; Genest J; Ko DT; Coutin AJS; Shan SD; Chu A
Angiology; 2019 Sep; 70(8):726-736. PubMed ID: 30871330
[TBL] [Abstract][Full Text] [Related]
3. Do statins reduce the incidence of stroke in familial hypercholesterolemia?
Vuorio AF; Kovanen PT
Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):349-53. PubMed ID: 21438814
[TBL] [Abstract][Full Text] [Related]
4. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.
Rallidis LS; Triantafyllis AS; Tsirebolos G; Katsaras D; Rallidi M; Moutsatsou P; Lekakis J
Atherosclerosis; 2016 Jun; 249():17-21. PubMed ID: 27062405
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
[TBL] [Abstract][Full Text] [Related]
7. Statin Therapy and Risk of Diabetes Mellitus in Aging Patients With Heterozygous Familial Hypercholesterolemia or Familial Combined Hyperlipidemia: A 10-Year Follow-Up.
Skoumas I; Ioakeimidis N; Vlachopoulos C; Chrysohoou C; Michalakeas C; Georgakopoulos C; Katsi V; Panagiotakos D; Tousoulis D
Angiology; 2018 Mar; 69(3):242-248. PubMed ID: 28681648
[TBL] [Abstract][Full Text] [Related]
8. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
[TBL] [Abstract][Full Text] [Related]
9. Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
Bos S; Duvekot MH; Ten Kate GR; Verhoeven AJ; Mulder MT; Schinkel AF; Nieman K; Watts GF; Sijbrands EJ; Roeters van Lennep JE
Atherosclerosis; 2017 Jan; 256():62-66. PubMed ID: 28012444
[TBL] [Abstract][Full Text] [Related]
10. Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia.
Harada-Shiba M; Sugisawa T; Makino H; Abe M; Tsushima M; Yoshimasa Y; Yamashita T; Miyamoto Y; Yamamoto A; Tomoike H; Yokoyama S
J Atheroscler Thromb; 2010 Jul; 17(7):667-74. PubMed ID: 20534948
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcomes in familial hypercholesterolemia: a registry-based study.
Toleikyte I; Retterstøl K; Leren TP; Iversen PO
Circulation; 2011 Oct; 124(15):1606-14. PubMed ID: 21911783
[TBL] [Abstract][Full Text] [Related]
12. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
Vishwanath R; Hemphill LC
J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
[TBL] [Abstract][Full Text] [Related]
13. Familial hypercholesterolemia in a large ambulatory population: Statin use, optimal treatment, and identification for advanced medical therapies.
Knickelbine T; Lui M; Garberich R; Miedema MD; Strauss C; VanWormer JJ
J Clin Lipidol; 2016; 10(5):1182-7. PubMed ID: 27678435
[TBL] [Abstract][Full Text] [Related]
14. A frequent variant in the ABCA1 gene is associated with increased coronary heart disease risk and a better response to statin treatment in familial hypercholesterolemia patients.
Versmissen J; Oosterveer DM; Yazdanpanah M; Mulder M; Dehghan A; Defesche JC; Kastelein JJ; Sijbrands EJ
Eur Heart J; 2011 Feb; 32(4):469-75. PubMed ID: 20595220
[TBL] [Abstract][Full Text] [Related]
15. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
16. Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.
Besseling J; Hovingh GK; Huijgen R; Kastelein JJP; Hutten BA
J Am Coll Cardiol; 2016 Jul; 68(3):252-260. PubMed ID: 27417002
[TBL] [Abstract][Full Text] [Related]
17. [Lipid Lowering Therapy with Statins in Patients with Heterozygous Familial Hypercholesterolemia].
Korneva VA; Kuznetsova TY; Tihova GP
Kardiologiia; 2019 Apr; 59(3):27-35. PubMed ID: 30990138
[TBL] [Abstract][Full Text] [Related]
18. Drug treatment and adherence of subjects <40 years with diagnosis of heterozygous familial hypercholesterolemia.
Casula M; Scotti L; Tragni E; Merlino L; Corrao G; Catapano AL
Atherosclerosis; 2016 Nov; 254():172-178. PubMed ID: 27750108
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.
Stein EA; Dufour R; Gagne C; Gaudet D; East C; Donovan JM; Chin W; Tribble DL; McGowan M
Circulation; 2012 Nov; 126(19):2283-92. PubMed ID: 23060426
[TBL] [Abstract][Full Text] [Related]
20. Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood.
Braamskamp MJ; Kusters DM; Wiegman A; Avis HJ; Wijburg FA; Kastelein JJ; van Trotsenburg AS; Hutten BA
Atherosclerosis; 2015 Aug; 241(2):427-32. PubMed ID: 26079405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
